NasdaqGS - Nasdaq Real Time Price USD

Insmed Incorporated (INSM)

Compare

65.25

-0.47

(-0.72%)

At close: January 10 at 4:00:02 PM EST

65.25

0.00

(0.00%)

After hours: January 10 at 5:03:43 PM EST

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today provided an update on the Company's commercial and clinical programs and its outlook for 2025. These updates will be discussed as part of the Company's presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT (6:00 p.m. ET).

PR Newswire yesterday

INSM
-0.72%
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 19 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

PR Newswire 7 days ago

INSM
-0.72%
Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT/6:00 p.m. ET.

PR Newswire 9 days ago

INSM
-0.72%
Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this […]

Insider Monkey 10 days ago

INSM
-0.72%
^GSPC
Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other biotech stocks. The Booming Biotechnology Sector The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and […]

Insider Monkey 19 days ago

INSM
-0.72%
5 Biotech Breakthrough Stocks to Watch in 2025

It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years

Zacks 19 days ago

OCGN

INSM
-0.72%
BEAM
Should You Invest in Insmed Incorporated (INSM)?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 6.50% (gross) and 6.24% (net), compared to an 8.41% return for the Russell 2000 Growth Index. Global markets performed fairly in […]

Insider Monkey last month

INSM
-0.72%
Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

CYTK
-1.58%
INSM
-0.72%
Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

KRYS

INSM
-0.72%
Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other high growth healthcare stocks. Global Healthcare Spending Trends and Investment Opportunities During lean economic times, investing in healthcare stocks is […]

Insider Monkey last month

INSM
-0.72%
Insmed To Present at December 2024 Investor Conferences

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

PR Newswire last month

INSM
-0.72%
Sector Update: Health Care Stocks Decline

Sector Update: Health Care Stocks Decline

PREMIUM
MT Newswires last month

INSM
-0.72%
NVO

INCY
Sector Update: Health Care Stocks Mixed Tuesday Afternoon

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

PREMIUM
MT Newswires last month

INSM
-0.72%
NVO
Insmed To Present at November 2024 Investor Conferences

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

PR Newswire 2 months ago

INSM
-0.72%
Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Review Insmed's (INSM) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks 2 months ago

INSM
-0.72%
Do You Believe in the Growth Potential of Insmed (INSM)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund appreciated 5.81%% (Institutional Shares) in the quarter compared to a 6.74% gain for the Russell 3000 Health Care Index (benchmark) and a 6.23% gain for the Russell […]

Insider Monkey 2 months ago

INSM
-0.72%
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

INSM posts wider-than-expected Q3 loss. The company plans to meet the FDA before 2024-end to discuss the possibility of an accelerated approval to expand Arikayce's label.

Zacks 2 months ago

INSM
-0.72%
Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Insmed ( NASDAQ:INSM ) Third Quarter 2024 Results Key Financial Results Revenue: US$93.4m (up 18% from 3Q 2023). Net...

Simply Wall St. 2 months ago

INSM
-0.72%
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Insmed Inc (INSM) reports robust financial performance with significant sales growth and strategic initiatives to support upcoming product launches.

GuruFocus.com 2 months ago

INSM
-0.72%
Q3 2024 Insmed Inc Earnings Call

Q3 2024 Insmed Inc Earnings Call

Thomson Reuters StreetEvents 2 months ago

INSM
-0.72%

Performance Overview

Return	INSM	S&P 500
YTD	-5.26%	-1.35%
1-Year	+124.15%	+22.51%
3-Year	+153.40%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Insmed Incorporated (INSM)

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

5 Biotech Breakthrough Stocks to Watch in 2025

Should You Invest in Insmed Incorporated (INSM)?

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insmed To Present at December 2024 Investor Conferences

Sector Update: Health Care Stocks Decline

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

Insmed To Present at November 2024 Investor Conferences

Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Do You Believe in the Growth Potential of Insmed (INSM)?

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Q3 2024 Insmed Inc Earnings Call

Performance Overview